Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells

Leukemia

Volumn 12, Issue 12, 1998, Pages 1903-1929

  McCubrey, J A ^a   Steelman, L S ^a   Hoyle, P E ^a   Blalock, W L ^a   Weinstein Oppenheimer, C ^a,b   Franklin, R A ^a   Cherwinski, H ^c   Bosch, E ^c   McMahon, M ^c  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Apoptosis; Autocrine growth; Raf; Signal transduction

Indexed keywords

CYTOKINE; ESTROGEN RECEPTOR; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PHENYLALANINE; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; TYROSINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

EID: 0031761118     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401215     Document Type: Article

References (35)

1. Lotem J, Sachs L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 1996; 10: 925-931.
2. Wang X-Y, Hoyle PE, McCubrey JA. Characterization of proteins binding specifically to the interleukin 3 (IL-3) mRNA 3′ untranslated region in IL-3-dependent and autocrine transformed cells. Leukemia 1998; 12: 520-531.
3. Wang XY, Steelman LS, McCubrey JA. Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: effects of mutations which result in autocrine growth factor stimulation and malignant transformation. Cytok Cell Mol Ther 1997; 3: 1-19.
4. Wang XY, McCubrey JA. Regulation of interleukin 3 expression in normal and autocrine transformed hematopoietic cells. Int J Oncol 1997; 10: 989-1001.
5. Wang XY, McCubrey JA. Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation. Leukemia 1997; 11: 1711-1725.
6. Drexler HG, Zaborski M, Quentmeier H. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia 1997; 11: 701-708.
7. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin. J Cell Physiol 1989; 140: 323-334.
8. Murate T, Saga S, Hotta T, Asano H, Ito T, Kato K, Tsuhita K, Kinoshita T, Ichikawa A, Yoshida S, Saito H. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell line K562, HEL and TF-1 into either erythroid or megakaryocytic lineages. Exp Cell Res 1993; 208: 35-43.
9. Trentesaux C, Nyoung MN, Aries A, Morceau F, Ronchi A, Ottolenghi S, Jardillier JC, Jeannesson P. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells. Leukemia 1993; 7: 452-457.
10. McCubrey JA, Steelman LS, Wang XY, Davidian EW, Hoyle PE, White C, Prevost KD, Algate PA, Robbins P, Mylott D, White MK. Autocrine growth factor secretion after transformation of human cytokine dependent cells by viral and cellular oncogenes. Int J Oncol 1995; 7: 573-586.
11. Hoyle PE, Steelman LS, McCubrey JA. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony-stimulating factor gene. Cytok Cell Mol Ther 1997; 3: 159-168.
12. Gabert JA, Lopez M, Bangs CD, Martina N, Donlon TA, Mannoni P, Lee F. Characterization of spontaneous factor-independent cell lines derived from the human leukemia cell line TF-1; a dominant event. Leukemia 1994; 8: 1359-1368.
13. Thacker JD, Hogge DE. Cytokine-dependent engraftment of human myeloid leukemic cell lines in immunosuppressed mice. Leukemia 1994; 8: 871-877.
14. Miyajima A, Kitamura T, Harada N, Yokota T, Aral K-L. Cytokine receptors and signal transduction. Annu Rev Immunol 1992; 10-295-331.
15. Algate PA, Steelman LS, Mayo MW, Miyajima A, McCubrey JA. Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line. Blood 1994; 83: 2450-2468.
16. Steelman LS, Algate PA, Blalock WL, Wang XY, Prevost KD, Hoyle PE, McCubrey JA. Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells. Leukemia 1996; 10: 528-542.
17. Kinoshita T, Yokata T, Arai K, Miyajima A. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J 1995; 14: 265-275.
18. Ihle JN, Witthuhn BA, Quell FW, Yamamoto K, Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 1995; 13: 369-399.
19. Morrison D. Mechanisms regulating Raf-1 activity in signal transduction pathways. Mol Rep Dev 1995; 42: 507-514.
20. Daum G, Eisenmann-Tappe I, Fries H-W, Troppmair J, Rapp UR. The ins and outs of Raf kinases. TIBS 1994; 19: 474-479.
21. Davis RJ. Transcriptional regulation by Map kinases. Mol Rep Dev 1995; 42: 459-167.
22. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995; 378: 307-310.
23. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, Basu S, McGinley M, Chan-Hui PY, Lichenstein H, Kolesnick R. Kinase suppressor of Ras is ceramine-activated protein kinase. Cell 1997; 89: 63-72.
24. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR. Protein kinase C activates Raf-1 by direct phosphorylation. Nature 1993; 364: 249-252.
25. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, Rapp U, Cooper GM. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 1997; 17: 732-741.
26. Marais R, Light Y, Mason C, Paterson H, Olson MF, Marshall CJ. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 1998; 280: 109-112.
27. Ueffinng M, Louric J, Philipp A, Mishak H, Kolch W. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity. Oncogene 1997; 15: 2921-2927.
28. Pazdrak K, Schreiber D, Forsythe P, Justemant L, Alam R. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of the lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J Exp Med 1995; 181: 1827-1834.
29. Chao TS, Abe M, Hershenson MB, Gomes I, Rooner MR. Src tyrosine kinase mediates stimulation of Raf-1 and mitogen-activated protein kinase by the tumor promoter thapsigargin. Mol Cell Biol 1997; 57: 3168-3173.
30. Diaz B, Barnard D, Filson A, MacDonald S, King A, Marshall M. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras dependent activation and biological signaling. Mol Cell Biol 1997; 17: 4509-4516.
31. Pena LA, Fuks Z, Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997; 53: 615-621.
32. Mark GE, Mac IR, Digan ME, Ambrosio L, Perrimon N. Drosophila melanogaster homologs of the raf oncogene. Mol Cell Biol 1987; 7: 2134-2140.
33. Samuels ML, Weber MJ, Bishop JM, McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 1993; 13: 6241-6252.
34. Pritchard CA, Samuels ML, Bosch E, McMahon M. Conditionally oncogenic forms of the A-raf and B-raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol 1995; 15: 9430-9442.
35. Bosch E, Cherwinski H, Peterson D, McMahon M. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene 1997; 11: 1021-1034.